Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed May 22, 2023 · 10-K · 51 days after period end · 0000313143-23-000014
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $304.42M | $265.00M | $225.03M | $238.49M |
| Net Income | $29.38M | $9.74M | -$11.04M | $17.62M |
| EPS Diluted | — | — | -$0.22 | $0.34 |
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Apr 1, 2023 · filed May 22, 2023 · 51 d after period end
